Literature DB >> 11513566

Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients.

G Riethmüller1, C A Klein.   

Abstract

Two clinical entities, unknown-primary cancer and inadvertent transmission of cancer with organ transplants are reviewed and discussed in the context of early and occult tumor cell dissemination. Both entities are taken as chief witnesses for cell dissemination being an early event in tumor progression. The involuntary transmission of tumor by organ grafts directly supports the notion that very few quiescent cells lodging at improbable sites such as kidney or heart suffice to generate de novo metastatic disease in the organ recipient. As to the nature of the cells and their biological and clinical significance a short review is given on the detection of disseminated cells in bone marrow and their prognostic significance for a metastatic relapse in patients with resected primary tumors. A novel single-cell genomic analysis is described, that allows the detection of multiple chromosomal aberration in single tumor cells. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11513566     DOI: 10.1006/scbi.2001.0386

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  40 in total

1.  Early tumor dissemination, but late metastasis: insights into tumor dormancy.

Authors:  Martin Röcken
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

2.  Epithelial cells disseminate into the bone marrow of colorectal adenoma patients.

Authors:  R Steinert; M Vieth; M Hantschick; M A Reymond
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Intra-tumoral Metastatic Double Primary Carcinoma: Synchronous Metastatic Tumor in Lung from Breast and Thyroid Carcinoma.

Authors:  Lee Chun Park; Ji Yun Jeong; Jun Ho Ji; Silvia Park; Jin Seok Ahn; Young-Hyuck Im; Yeon Hee Park
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

Review 4.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

5.  Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells.

Authors:  Michele I Vitolo; Michele B Weiss; Marta Szmacinski; Khola Tahir; Todd Waldman; Ben Ho Park; Stuart S Martin; David J Weber; Kurtis E Bachman
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

Review 6.  Genetic insights into the morass of metastatic heterogeneity.

Authors:  Kent W Hunter; Ruhul Amin; Sarah Deasy; Ngoc-Han Ha; Lalage Wakefield
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

Review 7.  Tumour heterogeneity and metastasis at single-cell resolution.

Authors:  Devon A Lawson; Kai Kessenbrock; Ryan T Davis; Nicholas Pervolarakis; Zena Werb
Journal:  Nat Cell Biol       Date:  2018-11-26       Impact factor: 28.824

Review 8.  Mouse modifier genes in mammary tumorigenesis and metastasis.

Authors:  Scott F Winter; Kent W Hunter
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

Review 9.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 10.  Mechanisms of metastasis.

Authors:  Kent W Hunter; Nigel P S Crawford; Jude Alsarraj
Journal:  Breast Cancer Res       Date:  2008       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.